MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
NeoGenomics Depreciation & Amortization 2011-2026 | NEO
Annual Depreciation & Amortization NeoGenomics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36.1 M | 39.1 M | 37.4 M | 35.4 M | 30.2 M | 25.9 M | 20.3 M | 15.8 M | 15.6 M | 15.9 M | 6.73 M | 5.34 M | 4.19 M | 3.64 M | 2.08 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 39.1 M | 2.08 M | 19.6 M |
Quarterly Depreciation & Amortization NeoGenomics
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.12 M | 9.37 M | - | 8.36 M | 8.36 M | 9.9 M | - | 8.78 M | 8.78 M | 9.05 M | - | 8.49 M | 8.49 M | 8.4 M | - | 21.8 M | 13.6 M | 6.68 M | - | 18.7 M | 12.2 M | 6.24 M | - | 15.2 M | 10.4 M | 5.27 M | - | 11.5 M | 7.44 M | 3.63 M | - | 11.7 M | 7.91 M | 3.98 M | - | 11.6 M | 7.33 M | 3.58 M | - | 4.97 M | 3.25 M | 1.59 M | - | 3.94 M | 2.4 M | 1.15 M | - | 3.12 M | 2.05 M | 990 K | - | 2.55 M | 1.6 M | 749 K | - | 1.48 M | 963 K | 488 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 21.8 M | 488 K | 6.96 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Agilent Technologies
A
|
321 M | $ 115.55 | 1.0 % | $ 35.1 B |  USA |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
1.11 M | $ 1.67 | -2.34 % | $ 2.22 M | USA |
 |
Castle Biosciences
CSTL
|
16 M | $ 24.46 | 3.25 % | $ 679 M | USA |
 |
CareDx, Inc
CDNA
|
15 M | $ 21.23 | 5.83 % | $ 1.13 B | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
70.1 M | $ 84.33 | 1.82 % | $ 5.69 B | USA |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 16.31 | 1.75 % | $ 493 M | USA |
 |
Medpace Holdings
MEDP
|
27.2 M | $ 410.54 | 4.35 % | $ 11.8 B | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M |  China |
 |
Charles River Laboratories International
CRL
|
403 M | $ 169.8 | 1.23 % | $ 8.42 B | USA |
 |
Guardant Health
GH
|
39.7 M | $ 88.91 | 1.18 % | $ 11.1 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
425 K | $ 1.98 | -2.37 % | $ 8.76 M | USA |
 |
Illumina
ILMN
|
354 M | $ 127.88 | 1.95 % | $ 20.3 B | USA |
 |
National Research Corporation
NRC
|
7.62 M | $ 17.23 | -0.12 % | $ 386 M | USA |
 |
Personalis
PSNL
|
10.9 M | $ 6.1 | 3.39 % | $ 361 M | USA |
 |
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B |  Niderland |
 |
Biomerica
BMRA
|
87 K | $ 2.14 | -0.47 % | $ 4.92 M | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 102.17 | -3.92 % | $ 8.43 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
681 M | $ 263.8 | -0.43 % | $ 21.9 B | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
Celcuity
CELC
|
167 K | $ 121.03 | 6.58 % | $ 5.66 B | USA |
 |
Thermo Fisher Scientific
TMO
|
1.05 B | $ 469.71 | 0.64 % | $ 177 B | USA |
 |
Neogen Corporation
NEOG
|
119 M | $ 9.54 | 2.03 % | $ 2.07 B | USA |
 |
Twist Bioscience Corporation
TWST
|
24.9 M | $ 60.94 | 3.55 % | $ 3.64 B | USA |
 |
Myriad Genetics
MYGN
|
53.7 M | $ 4.78 | -0.21 % | $ 443 M | USA |
 |
Natera
NTRA
|
16.7 M | $ 203.75 | 1.3 % | $ 20.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
570 M | $ 196.27 | -1.66 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
142 M | - | - | $ 21.2 M | USA |
 |
Organovo Holdings
ONVO
|
266 K | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
175 K | - | -16.95 % | $ 1.54 M | USA |
 |
Waters Corporation
WAT
|
88.1 M | $ 309.87 | -0.43 % | $ 18.5 B | USA |